ZyVersa Therapeutics ZVSA
OTC ZVSA
$0.00 -0.05 (-100.00%)
At close: Oct 20, 2026 · 4:00 PM EDT

ZyVersa Therapeutics, Inc. (ZVSA) Common Equity (2022 - 2026)

Updated

ZyVersa Therapeutics (ZVSA) reported Common Equity of -$14.12 million for Q1 2026, compared with $8.13 million a year earlier.

Analysis

ZyVersa Therapeutics, Inc. (ZVSA) Common Equity (2022 - 2026) Analysis & Trends

At the end of FY2025, ZyVersa Therapeutics posted Common Equity of -$12.39 million.

  • By year, Common Equity came in at $8.52 million in FY2024 (-23.1%), $11.07 million in FY2023 (-88.9%) and $99.68 million in FY2022.
  • The Q1 2026 figure ranks as the lowest quarterly Common Equity in data going back to Q1 2022.
  • Per Business Quant data, the three quarters before Q1 2026 came in at -$12.39 million (Q4 2025), -$11.73 million (Q3 2025) and $6.1 million (Q2 2025).
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 -14.12 Mn
Dec 31, 2025 -12.39 Mn
Sep 30, 2025 -11.73 Mn
Jun 30, 2025 6.10 Mn
Mar 31, 2025 8.13 Mn
Dec 31, 2024 8.52 Mn
Sep 30, 2024 7.03 Mn
Jun 30, 2024 8.62 Mn
Mar 31, 2024 11.22 Mn
Dec 31, 2023 11.07 Mn
Sep 30, 2023 19.70 Mn
Jun 30, 2023 20.06 Mn
Mar 31, 2023 97.10 Mn
Dec 31, 2022 99.66 Mn
Jun 30, 2022 -3.37 Mn
Mar 31, 2022 -2.98 Mn
API Access

ZyVersa Therapeutics, Inc. Common Equity API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=common-equity&ticker=ZVSA&period=max&api_key=YOUR_API_KEY